Correction to: Histamine induces the production of matrix metalloproteinase-9 in human astrocytic cultures via H1-receptor subtype (Brain Structure and Function, (2016), 221, 4, (1845-1860), 10.1007/s00429-015-1007-x);Histamine induces the production of matrix metalloproteinase-9 in human astrocytic cultures via H1-receptor subtype

Brain Structure and Function

Volumn 221, Issue 4, 2016, Pages 1845-1860

  Patel, Aarti ^a   Vasanthan, Vishnu ^a   Fu, Wen ^a   Fahlman, Richard P ^a   MacTavish, David ^a   Jhamandas, Jack H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Astrocytes; Histamine; Matrix metalloproteinase 9; Soluble oligomeric amyloid beta peptide

Indexed keywords

AMYLIN; AMYLOID BETA PROTEIN; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; HISTAMINE; HISTAMINE H1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; HISTAMINE AGONIST; MESSENGER RNA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; CALCIUM SIGNALING; CELL LINE, TUMOR; CELLS, CULTURED; HISTAMINE; HISTAMINE AGONISTS; HUMANS; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, HISTAMINE H1; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84923006883     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-024-02844-x     Document Type: Erratum

References (56)

1. Acharjee S, Zhu Y, Maingat F, Pardo C, Ballanyi K, Hollenberg MD, Power C (2011) Proteinase-activated receptor-1 mediates dorsal root ganglion neuronal degeneration in HIV/AIDS. Brain 134:3209–3221. doi:10.1093/brain/awr242
2. Akiyama H et al (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21:383–421
3. Arias-Montano JA, Berger V, Young JM (1994) Calcium-dependence of histamine- and carbachol-induced inositol phosphate formation in human U373 MG astrocytoma cells: comparison with HeLa cells and brain slices. Br J Pharmacol 111:598–608
4. Asahina M, Yoshiyama Y, Hattori T (2001) Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer’s disease brain. Clin Neuropathol 20:60–63
5. Asano K, Kanai KI, Suzaki H (2004) Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro. Clin Exp Allergy 34:1890–1898. doi:10.1111/j.1365-2222.2004.02127.x
6. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA (1996) Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J Neurosci 16:7910–7919
7. Bakker RA, Timmerman H, Leurs R (2002) Histamine receptors: specific ligands, receptor biochemistry, and signal transduction. Clin Allergy Immunol 17:27–64
8. Berman NE et al (1999) Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes. Neurobiol Dis 6:486–498. doi:10.1006/nbdi.1999.0261
9. Breunig E, Michel K, Zeller F, Seidl S, Weyhern CW, Schemann M (2007) Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J Physiol 583:731–742. doi:10.1113/jphysiol.2007.139352
10. Bruno MA, Leon WC, Fragoso G, Mushynski WE, Almazan G, Cuello AC (2009) Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease. J Neuropathol Exp Neurol 68:857–869. doi:10.1097/NEN.0b013e3181aed9e6
11. Bu X, Zhao C, Dai X (2011) Involvement of COX-2/PGE(2) pathway in the upregulation of MMP-9 expression in pancreatic cancer. Gastroenterol Res Pract 2011:214269. doi:10.1155/2011/214269
12. Carman-Krzan M, Vige X, Wise BC (1991) Regulation by interleukin-1 of nerve growth factor secretion and nerve growth factor mRNA expression in rat primary astroglial cultures. J Neurochem 56:636–643
13. Cheng CY, Kuo CT, Lin CC, Hsieh HL, Yang CM (2010) IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells. Br J Pharmacol 160:1595–1610. doi:10.1111/j.1476-5381.2010.00858.x
14. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277:32046–32053. doi:10.1074/jbc.M201750200
15. Deb S, Gottschall PE (1996) Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J Neurochem 66:1641–1647
16. Ding X, MacTavish D, Kar S, Jhamandas JH (2006) Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons. Neurobiol Dis 21:413–420. doi:10.1016/j.nbd.2005.08.016
17. Doyle JL, Haas TL (2009) Differential role of beta-catenin in VEGF and histamine-induced MMP-2 production in microvascular endothelial cells. J Cell Biochem 107:272–283. doi:10.1002/jcb.22123
18. Gschwandtner M, Purwar R, Wittmann M, Baumer W, Kietzmann M, Werfel T, Gutzmer R (2008) Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor. J Invest Dermatol 128:2783–2791. doi:10.1038/jid.2008.153
19. Haas H, Panula P (2003) The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4:121–130. doi:10.1038/nrn1034nrn1034
20. Hao F, Tan M, Xu X, Cui MZ (2008) Histamine induces Egr-1 expression in human aortic endothelial cells via the H1 receptor-mediated protein kinase Cdelta-dependent ERK activation pathway. J Biol Chem 283:26928–26936. doi:10.1074/jbc.M803071200
21. Hu WW, Chen Z (2012) Role of histamine and its receptors in cerebral ischemia. ACS Chem Neurosci 3:238–247. doi:10.1021/cn200126p
22. Inagaki N, Fukui H, Taguchi Y, Wang NP, Yamatodani A, Wada H (1989) Characterization of histamine H1-receptors on astrocytes in primary culture: [3H]mepyramine binding studies. Eur J Pharmacol 173:43–51. doi:10.1016/0014-2999(89)90007-1
23. Jhamandas JH, MacTavish D (2004) Antagonist of the amylin receptor blocks beta-amyloid toxicity in rat cholinergic basal forebrain neurons. J Neurosci 24:5579–5584. doi:10.1523/JNEUROSCI.1051-04.2004
24. Jones GJ et al (2007) HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. J Neurosci 27:3703–3711. doi:10.1523/JNEUROSCI.5522-06.2007
25. Juric DM, Mele T, Carman-Krzan M (2011) Involvement of histaminergic receptor mechanisms in the stimulation of NT-3 synthesis in astrocytes. Neuropharmacology 60:1309–1317. doi:10.1016/j.neuropharm.2011.01.019
26. Koistinaho M et al (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10:719–726. doi:10.1038/nm1058nm1058
27. Komatsu K, Nakanishi Y, Nemoto N, Hori T, Sawada T, Kobayashi M (2004) Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathol 21:105–112
28. Lacor PN et al (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27:796–807. doi:10.1523/JNEUROSCI.3501-06.2007
29. Leissring MA (2006) Proteolytic degradation of the amyloid beta-protein: the forgotten side of Alzheimer’s disease. Curr Alzheimer Res 3:431–435
30. Li SF, Wu MN, Wang XH, Yuan L, Yang D, Qi JS (2011) Requirement of alpha7 nicotinic acetylcholine receptors for amyloid beta protein-induced depression of hippocampal long-term potentiation in CA1 region of rats in vivo. Synapse 65:1136–1143. doi:10.1002/syn.20951
31. Lipnik-Stanglj M, Carman-Krzan M (2000) The effects of histamine and interleukin-6 on NGF release from cortical astrocytes in primary culture. Pflugers Arch 440:R99–R100
32. Lorenzl S, Buerger K, Hampel H, Beal MF (2008) Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia. Int Psychogeriatr 20:67–76. doi:10.1017/S1041610207005790
33. Maier CM, Hsieh L, Yu F, Bracci P, Chan PH (2004) Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia. Stroke 35:1169–1174. doi:10.1161/01.STR.0000125861.55804.f2
34. 2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades. Biochem Pharmacol 69:433–449. doi:10.1016/j.bcp.2004.10.006
35. Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S (2008) Abeta-degrading enzymes in Alzheimer’s disease. Brain Pathol 18:240–252. doi:10.1111/j.1750-3639.2008.00132.x
36. Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491–21494
37. Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease. Neurobiol Aging 25:663–674. doi:10.1016/j.neurobiolaging.2004.01.007
38. Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221–233. doi:10.1038/nrm2125
39. Panula P, Rinne J, Kuokkanen K, Eriksson KS, Sallmen T, Kalimo H, Relja M (1998) Neuronal histamine deficit in Alzheimer’s disease. Neuroscience 82:993–997
40. Rosenberg GA (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8:205–216. doi:10.1016/S1474-4422(09)70016-X
41. Ruangkittisakul A, Schwarzacher SW, Secchia L, Poon BY, Ma Y, Funk GD, Ballanyi K (2006) High sensitivity to neuromodulator-activated signaling pathways at physiological [K+] of confocally imaged respiratory center neurons in on-line-calibrated newborn rat brainstem slices. J Neurosci 26:11870–11880. doi:10.1523/JNEUROSCI.3357-06.2006
42. Saido TC (1998) Alzheimer’s disease as proteolytic disorders: anabolism and catabolism of beta-amyloid. Neurobiol Aging 19:S69–S75
43. Saito T, Takaki Y, Iwata N, Trojanowski J, Saido TC (2003) Alzheimer’s disease, neuropeptides, neuropeptidase, and amyloid-beta peptide metabolism. Sci Aging Knowledge Environ 2003:PE1
44. Selkoe DJ (2000) Toward a comprehensive theory for Alzheimer’s disease. Hypothesis: Alzheimer’s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann NY Acad Sci 924:17–25
45. Selkoe DJ (2002) Alzheimer’s disease is a synaptic failure. Science 298:789–791. doi:10.1126/science.1074069
46. Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278:11612–11622. doi:10.1074/jbc.M210207200
47. Tetlow LC, Woolley DE (2002) Histamine stimulates matrix metalloproteinase-3 and -13 production by human articular chondrocytes in vitro. Ann Rheum Dis 61:737–740
48. Turner AJ, Fisk L, Nalivaeva NN (2004) Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration. Ann NY Acad Sci 1035:1–20. doi:10.1196/annals.1332.001
49. Vehmas AK, Kawas CH, Stewart WF, Troncoso JC (2003) Immune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease. Neurobiol Aging 24:321–331
50. Wegiel J, Wang KC, Tarnawski M, Lach B (2000) Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta Neuropathol 100:356–364
51. Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease—a double-edged sword. Neuron 35:419–432
52. Wyss-Coray T et al (2003) Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9:453–457. doi:10.1038/nm838
53. Yan P et al (2006) Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J Biol Chem 281:24566–24574. doi:10.1074/jbc.M602440200
54. Yang BC, Chen RF, Chio CC, Chang WC, Lin MT, Lin SJ (1998) Effects of insulin on protein phosphorylation and protein kinase C activity in human malignant gliomas. Proc Natl Sci Counc Repub China B 22:22–30
55. Yin KJ et al (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J Neurosci 26:10939–10948. doi:10.1523/JNEUROSCI.2085-06.2006
56. Yoo HG et al (2002) IL-1beta induces MMP-9 via reactive oxygen species and NF-kappaB in murine macrophage RAW 264.7 cells. Biochem Biophys Res Commun 298:251–256